Small Bowel Obstruction Following Dislodgement of an Intragastric Balloon: A Case Report

Sep 25, 2024Cureus

Intestinal Blockage After an Intragastric Balloon Moved: A Case Report

AI simplified

GLP-1 Therapies on OpenScience ↗PubMed ↗DOI ↗

Abstract

A 30-year-old woman experienced severe abdominal complications 18 months after intragastric balloon placement, exceeding the recommended removal period.

Delayed removal of the intragastric balloon is associated with increased risks, including balloon rupture and gastric outlet obstruction.
Prolonged balloon retention correlates with higher complication rates, such as gastric perforation and small bowel obstruction.
Psychosocial evaluations may be necessary prior to weight loss procedures to ensure patient safety.
Alternative methods, like laparoscopic removal, may be required if endoscopic extraction fails.
The case emphasizes the need for rigorous follow-up care and patient education regarding procedural timelines.

AI simplified

Obesity remains a significant health burden worldwide, requiring diverse and effective treatment strategies. The intragastric balloon (IGB), developed in the 1980s, offers a non-surgical option for weight management. Despite a decrease in usage, the IGB procedure continues to be an option for patients both domestically and abroad. In this article, we present the case involving a 30-year-old female who presented with severe abdominal complications 18 months after IGB placement in the Dominican Republic, well beyond the recommended six-month period for removal. This case highlights the critical risks associated with delayed IGB removal, including balloon rupture, migration, and symptoms indicative of gastric outlet obstruction. The literature supports increased complication rates with prolonged balloon retention, including risks such as gastric perforation, ulceration, and small bowel obstruction, emphasizing the importance of adhering to removal schedules. Furthermore, the case stresses the need for psychosocial evaluations before weight loss procedures and the necessity of alternative methods like laparoscopic removal when endoscopic extraction is unsuccessful. As obesity management evolves with new treatments like glucagon-like peptide-1 (GLP-1) analogs, ongoing research to understand their interaction with IGBs is crucial. This case underlines the importance of rigorous follow-up care, educating patients about procedural timelines, and conducting comprehensive evaluations to ensure the safety and effectiveness of IGB therapy.

Full Text

We can’t show the full text here under this license. Use the link below to read it at the source.

View full text ↗

Small Bowel Obstruction Following Dislodgement of an Intragastric Balloon: A Case Report

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the glp-1 therapies brief